Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.
The recent approval by the US Food and Drug Administration (FDA) of the Absorb GT1 bioresorbable vascular scaffold (BVS) system (Abbott Vascular) got me thinking about a modern-day medical problem: ...
WASHINGTON, DC—Coronary stent infections are highly fatal and represent an understudied complication following PCI, a new analysis highlights. “Several important questions about coronary stent ...
SAN ANTONIO. -- CeloNova BioSciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigative device exemption (IDE) trial for its novel ...
The government has revised the maximum retail prices of coronary stents, used in the treatment of heart disease. The ...
A new report published Tuesday found over one in five coronary stents placed between 2019 and 2021 were unnecessary, costing Medicare $800 million a year and putting patients at risk of complications ...
While the placement of stents in newly reopened coronary arteries has been shown to reduce the need for repeat angioplasty procedures, researchers from the Duke Clinical Research Institute have found ...
DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...
Jaspal Rana, the Asian Games gold medalist shooter died of a heart attack this morning, days after reportedly getting his ...
The world's first drug-eluting bioresorbable plastic vascular scaffold (BVS) is now widely available across Europe and parts of Asia Pacific and Latin America. The Absorb BVS from Abbott (Abbott Park, ...
Drug-eluting stents (DES) have revolutionized the practice of interventional cardiology over the past decade. Although their efficacy has never been called into question, concerns have been raised ...
China's centralized procurement of coronary stents has benefited about 7 million patients by providing higher-quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results